Hospitals push back as FDA flags high markups on hospital consumables
Private hospitals' body Nathealth opposed the Maharashtra FDA's concerns over high markups on consumables, arguing that procurement costs do not reflect patient prices. Nathealth emphasized the need for a differentiated framework for pricing, distinguishing between basic and complex medical technologies. The debate continues as hospitals seek to clarify their role beyond mere resellers of medical devices.